ZELTIQ(R) Announces Conference Call and Webcast of Fourth Quarter and Full Year 2012 Financial Results on March 12, 2013
February 12 2013 - 4:05PM
ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology
company focused on developing and commercializing products
utilizing its proprietary controlled-cooling technology platform,
announced today that it plans to release its fourth quarter and
full year 2012 financial results on Tuesday, March 12, 2013 after
the market close.
ZELTIQ will hold a conference call on Tuesday, March 12, 2013,
at 5:00 p.m. ET to discuss the results. The dial-in numbers are
(877) 280-7291 for domestic callers and (707) 287-9361 for
international callers. A live webcast of the conference call will
be available online from the investor relations page of the
Company's corporate website at www.coolsculpting.com.
After the live webcast, the call will remain available on
ZELTIQ's website, www.coolsculpting.com, until ZELTIQ releases its
first quarter 2013 financial results. In addition, a telephonic
replay of the call will be available until March 19, 2013. The
replay dial-in numbers are (855) 859-2056 for domestic callers and
(404) 537-3406 for international callers. Please use the replay pin
number 99079360.
About ZELTIQ Aesthetics, Inc.
ZELTIQ® Aesthetics is a medical technology company focused on
developing and commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ's first commercial
product, the CoolSculpting® System, is designed to selectively
reduce stubborn fat bulges that may not respond to diet or
exercise. CoolSculpting is based on the scientific principle that
fat cells are more sensitive to cold than the overlying skin and
surrounding tissues.
CoolSculpting utilizes patented technology of precisely
controlled cooling to reduce the temperature of fat cells in the
treated area, which is intended to cause fat cell elimination
through a natural biological process known as apoptosis, without
causing scar tissue or damage to the skin, nerves, or surrounding
tissues. ZELTIQ developed CoolSculpting to safely, noticeably, and
measurably reduce the fat layer within a treated fat bulge without
requiring the patient to diet or exercise.
CONTACT: Investor Relations:
Patrick F. Williams
ZELTIQ, Senior Vice President and CFO
925-474-2500
Nick Laudico / Amy Glynn
The Ruth Group
646-536-7030 / 7023
nlaudico@theruthgroup.com
aglynn@theruthgroup.com
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024